.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Accenture
Queensland Health
Cantor Fitzgerald
Citi
Boehringer Ingelheim
Deloitte
Fish and Richardson
Cerilliant

Generated: January 20, 2018

DrugPatentWatch Database Preview

Dihydropyridine Calcium Channel Blocker Drug-Class List

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer IngelheimTWYNSTAamlodipine besylate; telmisartanTABLET;ORAL022401-001Oct 16, 2009ABRXYesNo➤ Subscribe➤ Subscribe➤ Subscribe
Boehringer IngelheimTWYNSTAamlodipine besylate; telmisartanTABLET;ORAL022401-003Oct 16, 2009ABRXYesNo➤ Subscribe➤ Subscribe➤ Subscribe
Boehringer IngelheimTWYNSTAamlodipine besylate; telmisartanTABLET;ORAL022401-002Oct 16, 2009ABRXYesNo➤ Subscribe➤ Subscribe➤ Subscribe
Boehringer IngelheimTWYNSTAamlodipine besylate; telmisartanTABLET;ORAL022401-004Oct 16, 2009ABRXYesYes➤ Subscribe➤ Subscribe➤ Subscribe
Daiichi SankyoTRIBENZORamlodipine besylate; hydrochlorothiazide; olmesartan medoxomilTABLET;ORAL200175-001Jul 23, 2010ABRXYesNo➤ Subscribe➤ Subscribe➤ Subscribe
Daiichi SankyoTRIBENZORamlodipine besylate; hydrochlorothiazide; olmesartan medoxomilTABLET;ORAL200175-002Jul 23, 2010ABRXYesNo➤ Subscribe➤ Subscribe➤ Subscribe
Daiichi SankyoTRIBENZORamlodipine besylate; hydrochlorothiazide; olmesartan medoxomilTABLET;ORAL200175-003Jul 23, 2010ABRXYesNo➤ Subscribe➤ Subscribe➤ Subscribe
Daiichi SankyoTRIBENZORamlodipine besylate; hydrochlorothiazide; olmesartan medoxomilTABLET;ORAL200175-004Jul 23, 2010ABRXYesNo➤ Subscribe➤ Subscribe➤ Subscribe
Daiichi SankyoTRIBENZORamlodipine besylate; hydrochlorothiazide; olmesartan medoxomilTABLET;ORAL200175-005Jul 23, 2010ABRXYesYes➤ Subscribe➤ Subscribe➤ Subscribe
Alembic Pharms LtdTELMISARTAN AND AMLODIPINEamlodipine besylate; telmisartanTABLET;ORAL205234-004Nov 17, 2016ABRXNoNo➤ Subscribe➤ Subscribe➤ Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Julphar
Daiichi Sankyo
US Army
McKesson
QuintilesIMS
Fish and Richardson
Medtronic
Novartis
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot